Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INVISIO launches the first headset that performs in all mission scenarios

INVISIO today launches a new innovative over-the-ear headset – the INVISIO T7. The tactical communication headset sets new standards for submersibility, ruggedness, flexibility, and comfort while combining industry-leading hearing protection with situational awareness. INVISIO has for many years led the market in advanced in-ear hearing protection headsets with situational awareness. The T7 headset extends that leadership to over-the-ear devices, combining the best of INVISIOs capabilities in tactical communication headsets. Designed for military and public safety professionals on

YIT starts planning to close down its Infrastructure business in Norway

YIT Corporation   Investor News     1 October 2020 at 9:45 a.m.YIT starts planning to close down its Infrastructure operations in Norway. The business in Norway scaled substantially down as a result of the sale of the Nordic paving and mineral aggregates businesses on 1 April 2020, and the outlook for the remaining Infrastructure business is weak. The potential exit from Norway is in line with YIT’s strategy to increase capital efficiency and to scale down operations which do not bring significant synergies or in which profitability does not meet the targets set. YIT will initiate co-

Airtours chooses Wallenstam and Birger Jarlsgatan 64

At Birger Jarlsgatan 64 in Stockholm, in the same property as Wallenstam’s Stockholm office, Sweden’s fourth largest tour operator Airtours is now moving into the fifth floor. This is a strategic choice as the business and all sales have been adapted to the fact that all trips are now arranged online and with personal service by telephone.“We have seen that our customers’ need for a physical store has almost completely disappeared so a move to a new premises without retail space feels totally natural,” says Stefan Chatzopoulos, Public Relations Manager at Airtours. Airtours was founded

Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

According to schedule, 2cureX’s clinical partner University Hospital Vejle today enrolled the last patient in the clinical validation study TICC1. In this interventional study, IndiTreat® test results guide the drug treatment of patients with metastatic colorectal cancer who have exhausted guideline-based treatment options.The TICC1 clinical trial (Clinicaltrials.gov no. NCT03251612) was launched end 2017 with the purpose of evaluating IndiTreat’s ability to successfully guide the drug therapy of end-stage metastatic colorectal cancer patients. As planned in the trial protocol, 45 patients

Digital solutions with potential to transform service within the rail industry

With the digital transformation of the rail industry, follows an increased demand for up-to-date service and maintenance information. By making sure service technicians get appropriate training and have access to the latest technical documentation, the cost of downtime can be reduced. Semcon is aiming to grow its business within rail as the demand for new service solutions is rapidly increasing.“At Semcon we see great potential for growth by providing digital documentation and training solutions for the rail industry. Today, we are one of the leading suppliers of product information to a

Subaru Selects Veoneer to Manufacture New Generation EyeSight

Stockholm, Sweden, October 1, 2020: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), has partnered with Subaru to introduce the new generation EyeSight on the all-new Subaru Levorg.  Veoneer will begin producing systems for the Japan market starting later this year.Veoneer was selected by Subaru due to its experience in stereo vision systems and opto-mechanical design capabilities. This business is included in Veoneer’s previously announced backlog.  The new generation EyeSight hardware is a variant of Veoneer’s 4[th] generation stereo vision system, re-

Alfa Laval opens new global Application & Innovation centre in Denmark

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – opens an Application & Innovation centre for fluid handling technology in Kolding, Denmark to strengthen the company's global position within food and pharmaceuticals, which are important growth areas for the company.The purpose of the new Application & Innovation centre is to accelerate the development of new product innovations within the hygienic fluid handling technology (including pumps, valves, cleaning and mixing equipment). The 1,600-square-metre center, located at Alfa Laval’s site in Kolding,

IRLAB's mesdopetam IND accepted by the US FDA

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the U.S. Food and Drug Administration (FDA) has accepted IRLAB's investigational new drug application (IND) for the drug candidate mesdopetam (IRL790). The acceptance of the IND will allow IRLAB to include US patients in the upcoming clinical trial in Parkinson's disease in accordance with the study protocol submitted with the IND application. The planned Phase IIb/III study for mesdopetam will thus include hospitals and enrol patients in the US and Europe. Mesdopetam is in development for the treatment of levodopa-induced dyskinesias in

SyntheticMR signs additional collaboration agreement with GE Healthcare MR

SyntheticMR announced today that they have signed an agreement with GE Healthcare to integrate their quantitative MRI solution SyMRI in GE’s platform. As part of the agreement, GE Healthcare will integrate the new SyMRI offering into their platform to provide faster workflows, unique physiologic information, and objective decision support leveraging quantification, to their customers globally.GE Healthcare currently sells a customized imaging solution, MAGiC, developed by SyntheticMR to their customers, which enables users to speed up their imaging workflow by generating multiple contrast-

Digia Hub is expanding – Digia is growing its freelancer network significantly with the acquisition of the consulting company NSD

Digia’s freelancer network, Digia Hub, will expand significantly as a result of the NSD acquisition. Digia Hub will now be able to provide a network of more than 1,800 professionals, through which companies in various sectors can directly acquire top experts for their own software development projects.On 1 October 2020, the owners of Digia Plc and NSD Consulting Oy signed an agreement by which Digia Plc will acquire the entire share capital of NSD Oy. NSD is a consulting company that specialises in demanding full-stack software development, particularly in Java and .NET environments. A

Nordic Capital sprints to EUR 6.1 billion Fund X in less than six months in wholly remote capital raise

· Tenth fund exceeds target of EUR 5 billion, closes at its hard cap with significant excess demand and is the largest fund raised in Nordic Capital’s history  · Very strong demand from a diversified blue-chip global base of new and returning investors with all due diligence conducted remotely  · Investors attracted to Nordic Capital’s leadership in its focus sectors, proven value-creation track record, high ESG ratings and resilient portfolio  · Fund X set to continue successful strategy of focusing on majority investments in non-cyclical growth companies in the Healthcare,

Gränges completes acquisition of GETEK GmbH and creates the new business unit Gränges Powder Metallurgy

Gränges’ previously announced acquisition of the remaining 49 per cent of the shares in GETEK GmbH was closed today. In connection with the acquisition, the name of the company will be changed to Gränges Powder Metallurgy GmbH and will constitute a new business unit within Gränges, focusing on advanced aluminium powder and spray forming technology. Today’s press release follows the announcement on 17 September 2020 of Gränges’ agreement to acquire the remaining 49 per cent of the shares in GETEK GmbH as well as the business Dispal[®], including production assets, intellectual properties

The most sensitive optical receivers yet for space communications

Communications in space demand the most sensitive receivers possible for maximum reach, while also requiring high bit-rate operations. A novel concept for laser-beam based communications, using an almost noiseless optical preamplifier in the receiver, was recently demonstrated by researchers at Chalmers University of Technology, Sweden. In a new paper published in the scientific journal Nature: Light Science & Applications, a team of researchers describes a free-space optical transmission system relying on an optical amplifier that, in principle, does not add any excess noise –

Africa Oil Announces Favorable Prime RBL Redetermination

VANCOUVER, October 1, 2020 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“AOI”, “Africa Oil” or “the Company”) is pleased to provide an update on Prime Oil & Gas B.V. (“Prime”) Reserve Base Lending facility (“RBL”). Africa Oil has a 50% shareholding in Prime, a company with deepwater producing assets offshore Nigeria. The September redetermination of the Prime RBL has been approved by the banking syndicate with a total principal amortisation for 2020 of US$522 million. This is US$108 million less than management’s initial guidance of US$630 million as announced on February

Atria acquires the entire share capital of Domretor

Atria Finland has acquired the entire share capital of Domretor Oy, a contract manufacturer in the food industry located in Kauhava, in an acquisition completed on September 30, 2020. Domretor Oy has been an associated company of Atria since 2013, when Atria acquired a 24.9 percent stake in Domretor. Domretor started operations in 1999 and is a contract manufacturer of high-quality convenience food products and semi-finished products. - With the acquisition, Atria will further strengthen its position in the retail convenience food selections and in the market for Food Service products.

Itiviti’s sell-side OMS recognized for Best Equity Trading System of the Year at FOW Asia Capital Markets Awards

Singapore, October 1, 2020 – Itiviti, a leading technology, and service provider of electronic trading and connectivity solutions to financial institutions worldwide, today announced that Itiviti’s sell-side OMS has won Best Equity Trading System of the Year at the FOW Asia Capital Markets Awards. The awards are judged by a panel of industry experts from across the market.Luke Jeffs, Managing Editor, Global Investor, commented: “Itiviti has demonstrated its market leadership by continuing to diversify its services and enhancing its trading technology in Asia. The Equity Trading System of

Mentice engages Pareto Securities as liquidity provider

Mentice AB (publ), a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, engages Pareto Securities as liquidity provider Mentice AB (publ) has entered into an agreement with Pareto Securities whereby Pareto Securities will act as liquidity provider for the Mentice share. The assignment takes place within the framework of Nasdaq First North Growth Market’s liquidity provision rules and means that the liquidity provider quotes a buy and sell volume corresponding to at least SEK 20,000, with a maximum spread of 4% between

Vicore Pharma announces completion of patient enrollment in the COVID-19 ATTRACT trial

Gothenburg, October 1, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces that the last patient has been randomized in the ATTRACT COVID-19 VP01 trial.The last patient in the ATTRACT (Angiotensin II Type Two Receptor Agonist Covid-19 Trial) study has now been randomized and will be treated for up to one week and then followed up for another week. Thereafter, the data is quality controlled and the database will be locked before the study is unblinded for analysis. Top-line results are expected

Oncopeptides initiates U.S. Expanded Access Program with melflufen in triple-class refractory multiple myeloma

STOCKHOLM — October 1, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) announced today that the open-label Expanded Access Program, sEAPort , for eligible U.S. patients, is formally open. Melflufen (INN melphalan flufenamide), is currently being evaluated in several clinical studies as a treatment for patients with triple-class refractory multiple myeloma. The sEAPort program is available to adults, age 18 and older, who have received at least two prior lines of therapy and whose multiple myeloma is refractory to at least one

H & M Hennes & Mauritz AB Nine-month report

Nine months (1 December 2019 – 31 August 2020) · The H&M group’s net sales amounted to SEK 134,482 m (171,061) in the first nine months of the financial year. Sales development was significantly negatively affected by the Covid-19 situation, particularly in the second quarter when stores were temporarily closed in most markets; at the most, approximately 80 percent of the group’s stores were closed. · Profit after financial items amounted to SEK –1,613 m. The group’s profit after tax amounted to SEK –1,242 m, corresponding to SEK –0:75 per share. Excluding IFRS 16, profit after

KONECRANES AND CARGOTEC TO MERGE CREATING A GLOBAL LEADER IN SUSTAINABLE MATERIAL FLOW

KONECRANES PLC INSIDE INFORMATION 1 OCTOBER 2020 AT 9:00 A.M. EEST NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW konecranes and cargotec TO MERGE CREATING A GLOBAL LEADER IN SUSTAINABLE MATERIAL FLOW Konecranes Plc (“Konecranes”) and Cargotec Corporation (“Cargotec”) announce that their respective Boards of Directors have today signed a combination agreement (the “Combination Agreement”) and a merger plan to combine the two companies through a merger (the “Future Company”).

Realheart launches scientific advisory board

Realheart is now launching a scientific advisory board with experts who will help the company to quickly and safely commercialize its artificial heart. The board has three well-established experts: the thoracic surgeon Robert D. Dowling, prof. emeritus Henrik Ahn and prof. Zoltán Szabó.Realheart's scientific advisory board is a panel of experts with relevant specialist competence that will advise the company in research work and product development, for example on preclinical and clinical studies. But with its strong links to the market, the board also provides access to knowledge about the

Top executives from unicorns Oak North Bank and Klarna to join DBTs Board of Directors

Hanna Jacobsson with a background as CRO at Klarna has together with Chris Dailey former CEO at Oak North Bank been appointed to DBT’s Board of Directors. From the left: Hanna Jacobsson and Chris Dailey. Photo credit: Rickard Eriksson and DBTDBT has since start had a clear focus of building the next generation SME-lender. After having built the initial tech, team and funding platform DBT’s strengthens its Board of Directors for the next phase of their growth journey.“I am very proud to have Hanna and Chris, share our commitment to enable innovation and growth opportunities for SME’

Photocure launches European Hexvix operations

Oslo, Norway, 1 October 2020: Photocure ASA (OSE:PHO) today announces the commencement of the sales, marketing and distribution of Hexvix[®] in the European markets formerly operated by Ipsen Pharma SAS (Ipsen). The successful transition and launch of European Hexvix operations creates a robust platform for accelerated growth and expansion for Photocure."We are proud to announce the launch of our European Hexvix operations which will transform Photocure into a strong global business within the diagnosis and treatment of bladder cancer. We have built a successful commercial organization for

There are no items matching the current filter
There are no more items matching the current filter
Back to top